This site is intended for Healthcare professionals only.

New class of drugs could combat antibiotic resistance


New class of drugs could combat antibiotic resistance

New York  :  Researchers have discovered a new class of drugs that boosts the effect of antibiotics on disease-causing bacteria and holds promise for combating resistance to antibiotics.

“In contrast to previous approaches, our new mechanism uses mechanics to revive an existing antibiotic’s ability to fight infection,” said one of the researchers Jeremy Smith from University of Tennessee-Oak Ridge National Laboratory Center for Molecular Biophysics in the US.

Combining laboratory experiments with super computing modeling, the researchers identified four new chemicals that seek out and disrupt bacterial proteins called “efflux pumps”, a major cause of antibiotic resistance in bacteria, according to the study published in the American Chemical Society’s Infectious Diseases journal.

The team focused on one efflux pump protein, known as AcrA, which connects two other proteins in a tunnel shape through the bacterial cell envelope.

Disrupting this protein could essentially break the efflux pump – an approach unlike other drug design strategies that try to inhibit the biochemical processes.

The laboratory experiments were done jointly with extensive protein simulations run on Oak Ridge National Laboratory’s Titan supercomputer.

“The super computing power of ORNL’s Titan supercomputer allowed us to perform large-scale simulations of the drug targets and to screen many potential compounds quickly,” said Helen Zgurskaya, Professor at University of Oklahoma.

Large numbers of chemicals were scanned to predict and select which would be the most effective in preventing AcrA proteins from assembling properly.

Using computational models produced by the Titan supercomputer, the researchers screened various combinations of molecules and proteins to determine which ones were most disruptive to their formation.

The researchers then conducted laboratory experiments to confirm the disruption of the efflux pump and the antibiotic-reviving capability of four of the molecules selected.

The Saint Louis University School of Medicine research team then synthesised structural analogs of the discovered efflux pump inhibitors and identified properties essential for their activities.

The following two tabs change content below.
supriya kashyap

supriya kashyap

Supriya Kashyap Joined Medical Dialogue as Reporter in 2015 . she covers all the medical specialty news in different medical categories. She also covers the Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in medical filed. She is a graduate from Delhi University. She can be contacted at supriya.kashyap@medicaldialogues.in Contact no. 011-43720751
Source: IANS

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted